Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 38 of 38 entries
View as:

Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia

Phase: N/A Priority: Normal
NCT ID: NCT02078310 Org: User:
Start: 02/28/14 End: 11/30/14 Due: 11/30/15

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT06690398 Org: User:
Start: 11/22/24 End: 04/30/27 Due: 04/30/28

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04285515 Org: User:
Start: 02/27/20 End: 11/30/22 Due: 11/30/23

Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03387215 Org: User:
Start: 07/10/18 End: 03/16/20 Due: 03/16/21

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06540833 Org: User:
Start: 08/15/24 End: 10/31/27 Due: 10/31/28

Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02288845 Org: User:
Start: 10/31/14 End: 09/30/15 Due: 09/30/16

Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement

Phase: N/A Priority: Normal
NCT ID: NCT03489772 Org: User:
Start: 07/10/18 End: 08/05/19 Due: 08/05/20

Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05061706 Org: User:
Start: 09/30/21 End: 04/12/24 Due: 04/12/25

A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05470101 Org: User:
Start: 07/26/22 End: 05/03/23 Due: 05/03/24

PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06299410 Org: User:
Start: 04/11/24 End: 09/30/25 Due: 09/30/26

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05732194 Org: User:
Start: 01/18/23 End: 09/01/23 Due: 09/01/24

Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06557902 Org: User:
Start: 05/10/24 End: 07/31/26 Due: 07/31/27

Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04779177 Org: User:
Start: 03/12/21 End: 07/30/22 Due: 07/30/23